Companies

Eli Lilly

Eli Lilly develops medicines across diabetes, obesity, oncology, and neuroscience, including its market-defining incretin therapies. Its Lilly Research Laboratories maintain extensive academic alliances and AI partnerships to expand its pipeline.

Details

Industry

Biopharma

R&D Spend

$9.0B